Rang	Name	Position
1	Dr. Jayson M. Rieger M.B.A., Ph.D.	President, CEO & Director
2	Mr. John J. Kirby CPA	Interim Chief Financial Officer
3	Dr. Noah L. Rosenberg M.D.	Chief Medical Officer
4	Mr. David Zawitz	COO, Chief Legal Officer & Secretary
5	Mr. Eugene Scavola	Executive Vice President of Technical Operations
6	Dr. Bradley J. Catalone MBA, Ph.D.	Head of Drug Development
7	Mr. Chris Chapman	Chief Commercial Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Caligan Partners LP	5,38%	4,98 Mio. USD
2	Cannell Capital LLC	4,56%	4,23 Mio. USD
3	Affinity Asset Advisors, LLC	4,12%	3,81 Mio. USD
4	Armistice Capital, LLC	3,02%	2,79 Mio. USD
5	Velan Capital Investment Management LP	2,75%	2,54 Mio. USD
6	BOOTHBAY FUND MANAGEMENT, LLC	1,63%	1,51 Mio. USD
7	Vanguard Capital Management, LLC	1,10%	1,02 Mio. USD
8	Dafna Capital Management LLC	0,89%	0,83 Mio. USD
9	Marshall Wace Asset Management Ltd	0,82%	0,76 Mio. USD
10	Geode Capital Management, LLC	0,81%	0,75 Mio. USD
11	Stonepine Capital Management Llc	0,58%	0,54 Mio. USD
12	Squarepoint Ops LLC	0,44%	0,41 Mio. USD
13	Vanguard Fiduciary Trust Co	0,38%	0,35 Mio. USD
14	Two Sigma Investments LLC	0,29%	0,27 Mio. USD
15	Jane Street Group LLC	0,29%	0,27 Mio. USD
16	BlackRock Inc	0,22%	0,21 Mio. USD
17	Renaissance Technologies Corp	0,19%	0,17 Mio. USD
18	Northern Trust Corp	0,18%	0,17 Mio. USD
19	State Street Corp	0,17%	0,16 Mio. USD
20	Mariner Wealth Advisors LLC	0,14%	0,13 Mio. USD